The somewhat lower rates of MTAP deficiency in NGS studies may be due to the notoriously low tumor cell density in pancreatic adenocarcinomas, which are characterized by a dense desmoplastic stroma and large distances between invasively growing tumor cell glands. This evidence concerns the gene MTAP and pancreatic adenocarcinoma.